VANI Receives Approval
Vivani Medical receives regulatory approval for a Phase 1 clinical trial of NPM-139 Semaglutide Implant
VANI - Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management